title: Rapidly growing ulcer in a patient with neurofibromatosis type I.
authors.affiliation: Servicio de Dermatología, Hospital General Universitario de Alicante, Spain. ftoledo@coma.es
authors.forename: F
authors.initials: F
authors.lastname: Toledo-Alberola
authors.forename: J
authors.initials: J
authors.lastname: Guijarro-Llorca
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000150:complications; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001374:Azacitidine / Q000009:adverse effects / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007037:Hypothyroidism / Q000150:complications; D016867:Immunocompromised Host; D007871:Leg Ulcer / Q000209:etiology* / Q000382:microbiology; D015477:Leukemia, Myelomonocytic, Chronic / Q000150:complications / Q000188:drug therapy; D017254:Leukemic Infiltration / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D009456:Neurofibromatosis 1 / Q000150:complications*; D010673:Pheochromocytoma / Q000150:complications; D011552:Pseudomonas Infections / Q000209:etiology* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000209:etiology* / Q000382:microbiology
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine